The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood

Keisuke Katsushima1,2, Rudramani Pokhrel1,2, Iqbal Mahmud3,4

  • 1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, 1650 Orleans St., Baltimore, MD, 21231, USA.

Insights

A novel circular RNA, circ_63706, drives medulloblastoma growth in the SHH subgroup. Depleting circ_63706 reduced tumor size and improved survival, highlighting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Medulloblastoma (MB) is a complex brain tumor with poorly understood roles for non-coding RNAs (ncRNAs).
  • Circular RNAs (circRNAs), a class of ncRNAs, are emerging as potential therapeutic targets in cancer, but their function in MB is largely unknown.

Purpose of the Study:

  • To identify medulloblastoma subgroup-specific circRNAs.
  • To characterize the function and molecular mechanisms of a novel circRNA, circ_63706, in the sonic hedgehog (SHH) MB subgroup.

Main Methods:

  • RNA sequencing (RNA-seq) analysis of 175 MB patient samples to identify subgroup-specific circRNAs.
  • RNA fluorescence in situ hybridization (RNA-FISH) for expression validation.
  • In vitro and in vivo functional assays (cell depletion, tumor implantation in mice).
  • RNA-seq and lipid profiling of circRNA-depleted cells.
  • Bioinformatic analysis including random forest classification for secondary structure mapping and 3D modeling.

Main Results:

  • Identified circ_63706 as specific to the SHH MB subgroup, independent of its host gene PCNT.
  • Depletion of circ_63706 significantly reduced tumor growth in vivo and prolonged mouse survival.
  • Molecular analysis revealed circ_63706 depletion altered lipid metabolism, increasing ceramides and oxidized lipids while decreasing triglycerides.
  • Mapped circ_63706 secondary structure and modeled its 3D structure to predict miRNA interactions.

Conclusions:

  • Circ_63706 is a novel oncogenic circRNA in the SHH medulloblastoma subgroup.
  • Circ_63706 plays a critical role in MB tumorigenesis and influences lipid metabolism.
  • Circ_63706 represents a promising therapeutic target for SHH medulloblastoma.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K